Universal Display Corporation — Q1 2012 Form 10-Q Summary
Business context and reporting period
Universal Display develops and commercializes OLED technologies and materials for flat-panel displays, solid-state lighting and other applications. Revenue is generated from OLED material sales, intellectual-property licensing, and technology development and support. The filing covers the three months ended March 31, 2012, compared with the three months ended March 31, 2011. Financial statements are unaudited.
Key financial metrics
| Metric | Q1 2012 | Q1 2011 | Change |
|---|---|---|---|
| Total revenue | $12.6 million | $9.6 million | Up 31% |
| Material sales | $10.5 million | $4.5 million | Up $6.0 million |
| Royalty and license fees | $0.4 million | $2.7 million | Down $2.2 million |
| Technology development and support revenue | $1.7 million | $2.4 million | Down $0.7 million |
| Operating loss | $1.6 million | $2.7 million | Improved $1.2 million |
| Net loss | $1.2 million | $11.9 million | Improved $10.7 million |
| Loss per diluted share | $0.03 | $0.31 | Improved |
| Operating cash flow | $(2.0) million | $1.6 million | Declined $3.6 million |
Operating margin was approximately negative 12.3% in Q1 2012 versus negative 28.6% in Q1 2011. Net margin was approximately negative 9.7% versus negative 123.7%, respectively. The 2011 results included an $8.9 million non-cash loss on the stock warrant liability; all remaining warrants were exercised in 2011, so no comparable charge occurred in 2012.
- Operating expenses were $14.2 million, up from $12.3 million. Research and development expense was $6.7 million, selling, general and administrative expense was $4.3 million, and patent costs were $1.9 million.
- Cost of material sales was $1.1 million versus $0.1 million, reflecting increased commercial material sales. The filing does not present a consolidated gross margin.
- Interest income increased to $0.4 million from $0.1 million due to higher average cash and investment balances.
- Cash and cash equivalents were $144.3 million at March 31, 2012. Short-term investments were $194.3 million and long-term investments were $1.0 million, for total cash and investments of approximately $339.6 million.
- Total liabilities were $29.3 million; the filing does not report outstanding debt. Working capital was $338.0 million.
- Total assets were $369.2 million and shareholders’ equity was $339.9 million at March 31, 2012.
Material changes versus the prior comparable period
- Revenue growth was driven primarily by increased OLED material sales associated with broader adoption by display manufacturers, particularly Samsung Mobile Display.
- Material sales composition shifted toward host materials: phosphorescent emitter materials represented 81% of material sales compared with 95% in Q1 2011; host materials represented 19% compared with 5%.
- Royalty and license revenue declined because payments under the August 2011 Samsung Mobile Display patent license are scheduled in the second and fourth quarters rather than quarterly. No installment was due in Q1 2012.
- Research and development expense was broadly stable, while SG&A and patent costs increased. Certain compensation accrual reversals reduced Q1 2012 R&D expense by $0.6 million and SG&A expense by $0.3 million.
- Operating cash flow turned negative, primarily due to timing of accounts-payable payments, inventory purchases and other current-asset payments.
- Investing activities provided $37.3 million, principally from net sales of investments. Financing activities used $2.9 million, compared with $251.0 million provided in Q1 2011, when the company completed a public offering.
Guidance, outlook, commentary, risks and unusual items
- Management expects quarterly and annual results to fluctuate based on the timing of license fees and royalties, material sales volumes, research and development spending, and new business relationships.
- No specific revenue, earnings or margin guidance is provided. Management expects existing cash, cash equivalents and short-term investments to fund obligations for at least the next 12 months.
- The company remains loss-making, with an accumulated deficit of $215.1 million, and states that additional financing may eventually be required for research, commercialization, patent activities, working capital or other purposes.
- Customer concentration is significant: one customer represented 42% of Q1 2012 revenue, and two additional customers represented 13% and 12%. Agreements with the latter two customers were scheduled to expire in less than twelve months.
- International revenue represented 90% of total revenue, with South Korea accounting for $7.4 million, or approximately 59%, of Q1 2012 revenue. All chemical materials were purchased from one supplier.
- Host-material sales are described as more competitive and their long-term prospects are uncertain. Material sales may also fluctuate with customer product updates, pricing, availability and competing products.
- The company is defending numerous patent oppositions and invalidation proceedings in Europe, Japan and Korea involving key OLED technology patents. Management believes the challenged patents will generally be upheld but provides no assurance; the company is responsible for related legal costs under its license arrangements.
- The company was obligated to pay up to $2.1 million to USC for work performed through the April 30, 2013 extended research-agreement term and incurred $1.3 million in Q1 2012 expense related to PPG Industries services and reimbursements.
- No off-balance-sheet arrangements were reported, and management concluded that disclosure controls and procedures were effective as of March 31, 2012.
Important facts for investors to verify
- Whether increased OLED material sales, particularly to Samsung Mobile Display, continue and whether customer concentration declines.
- The timing and amount of Samsung Mobile Display license installments, which are concentrated in the second and fourth quarters.
- Conversion of revenue growth into sustained operating profitability and positive operating cash flow.
- Expiration, renewal and minimum-purchase terms for customer agreements scheduled to expire within twelve months.
- Dependence on a single chemical-material supplier and the competitive outlook for host materials.
- Progress and outcomes of the numerous patent oppositions and invalidation proceedings, including potential effects on licensing and commercialization rights.
- Future patent, research and development, and commercialization spending, together with the potential need for additional financing.